Product Overview

Fertigyn 10000 IU is a pharmaceutical preparation that contains Human Chorionic Gonadotropin (HCG) at a strength of 10,000 International Units per vial. Manufactured by Sun Pharmaceutical Industries Ltd, this product is supplied as a single injection in a sealed vial and is available in pack sizes of 3, 6, or 9 vials. It is indicated for the treatment of female infertility and male hypogonadism, offering a clinically validated option for patients and clinicians seeking assisted reproductive outcomes.

What is Fertigyn 10000 IU

Human Chorionic Gonadotropin (HCG) is a glycoprotein hormone that mimics the action of luteinizing hormone (LH) and follicle‑stimulating hormone (FSH). The 10,000 IU formulation marketed as Fertigyn is chemically identical to endogenous HCG and is used to stimulate gonadal function in both women and men. According to the National Institutes of Health (NIH), HCG plays a pivotal role in regulating steroidogenesis and gametogenesis, making it a cornerstone in reproductive endocrinology.

Uses and Benefits

Fertigyn 10,000 IU is primarily prescribed for two therapeutic areas:

• Female Infertility: Used to induce ovulation in women with anovulation or polycystic ovary syndrome (PCOS) when other agents are ineffective. It also supports luteal phase supplementation in assisted reproductive technology (ART) cycles.
• Male Hypogonadism: Administered to stimulate testosterone production in men with deficient gonadal function, often as part of fertility preservation protocols.

The benefits of using a standardized 10,000 IU dose include predictable pharmacodynamics, ease of dosing, and a well‑documented safety profile when administered under medical supervision. Real‑world studies referenced on PubMed demonstrate improved ovulation rates and increased pregnancy outcomes when HCG is integrated into IVF regimens.

How It Works

The mechanism of action of HCG involves binding to the LH/FSH receptors on ovarian theca cells and Leydig cells in the testes. This binding triggers intracellular signaling pathways that increase cyclic AMP production, leading to enhanced production of sex steroids. In women, the hormonal surge mimics the natural LH surge, prompting follicular maturation and ovulation. In men, the stimulation results in increased testosterone synthesis, which can restore spermatogenesis and improve libido.

Pharmacokinetic data from the U.S. Food and Drug Administration (FDA) indicate that HCG is administered intramuscularly or subcutaneously, with peak serum concentrations occurring within 6–12 hours post‑injection. The drug’s half‑life varies depending on the formulation but generally supports sustained endocrine activity for several days.

Dosage Guidelines

Dosage of Fertigyn 10,000 IU must be individualized based on the clinical indication, patient age, weight, and response to therapy. Typical regimens include:

• Female Infertility: A single 10,000 IU dose administered intramuscularly or subcutaneously after ovarian stimulation, often on the day of the LH surge or as a trigger for final oocyte maturation.
• Male Hypogonadism: Weekly intramuscular injections of 10,000 IU for 4–6 weeks, with dosing adjustments guided by serum testosterone levels.

Patients should always adhere to the dosing schedule prescribed by their treating physician. The MedlinePlus resource emphasizes that missed doses should not be doubled; instead, the next scheduled dose should be given as planned.

Side Effects

Like all hormonal medications, Fertigyn can produce adverse effects. Most side effects are mild and self‑limiting, but clinicians should be aware of the full spectrum:

• Injection site reactions – pain, redness, or swelling.
• Headache, fatigue, or mild abdominal discomfort.
• Nausea or vomiting, particularly in women receiving fertility treatment.
• In rare cases, ovarian hyperstimulation syndrome (OHSS) may occur, characterized by abdominal distension, rapid weight gain, and shortness of breath.
• Allergic reactions – rash, pruritus, or anaphylaxis (extremely rare).

Patients are advised to report any severe or persistent symptoms to their healthcare provider promptly.

Warnings and Precautions

Before initiating therapy with Fertigyn 10,000 IU, several precautions should be observed:

• Contraindications: Known hypersensitivity to HCG or any component of the formulation; active or suspected pregnancy unless used for therapeutic termination.
• Pregnancy and Lactation: HCG may cross the placental barrier; use only when clearly indicated.
• Thromboembolic Risk: Patients with a history of thromboembolic disorders should be evaluated carefully, as HCG can theoretically increase clotting factors.
• Drug Interactions: Concomitant use of other gonadotropins or hormonal therapies may require dose adjustments.

Regular laboratory monitoring — including serum testosterone, estradiol, and luteinizing hormone levels — helps ensure therapeutic efficacy while minimizing complications. References from Drugs.com provide additional guidance on monitoring protocols.

Frequently Asked Questions

1. What is the difference between Fertigyn 10,000 IU and lower‑strength HCG products?

   Fertigyn 10,000 IU delivers a higher dose of HCG per vial, which reduces the number of injections required and is often preferred in protocols that demand a single, potent trigger dose.

2. Can Fertigyn be used for weight loss?

   No. HCG therapy for weight loss lacks robust clinical evidence and is not an approved indication. Its use should be limited to medically supervised reproductive or endocrine indications.

3. How should the vial be stored?

   Unopened vials should be kept refrigerated at 2‑8°C (36‑46°F). Once punctured, the vial can be stored at room temperature for up to 30 days, provided it is protected from light and used before the expiration date.

4. Is Fertigyn safe for patients with polycystic ovary syndrome (PCOS)?

   Yes, when administered under medical supervision. However, clinicians may start with a lower dose and monitor ovarian response closely to reduce the risk of OHSS.

5. Where can I find more detailed prescribing information?

   Comprehensive prescribing details are available on the manufacturer’s website and through the Wikipedia entry on Human Chorionic Gonadotropin, which aggregates data from FDA label submissions and peer‑reviewed studies.

For further reading and evidence‑based guidance, clinicians and patients can explore resources from the NIH, PubMed, and the FDA. Always consult a qualified healthcare professional before initiating or modifying any HCG therapy.

Related Products

• Famotidine 20mg (Generic)
• Omesec 20 mg (Omeprazole)
• Pantocid DSR (Pantoprazole/Domperidone)
• Famotidine 40mg (Generic)
• Famocid 20mg (Famotidine)
• Famocid 40mg (Famotidine)
• Famocid (Famotidine)
• Supatret 0.04% Gel (Tretinoin)
• Supatret 0.1% Gel (Tretinoin)
• Supatret C Gel (Clindamycin/Tretinoin)
• Supatret Gel (Tretinoin)
• Acitretin 25mg (Generic)